TCL Archive Patient Advocacy: MBCC Conference Issues Statement On Equal Status On Advocates April 4, 1997
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012
TCL Archive Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin January 16, 2009
TCL Archive FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening April 25, 2014
TCL Archive Michigan Scientist David Beer Sought Retraction Of Potti’s NEJM Paper Over Misuse Of His Data July 30, 2010
